Drug Target Pharmacodynamics Flashcards

1
Q

Question: How are drugs defined, and what is their primary purpose in a biological system?

A

Answer: Drugs are molecules that interact with a biological system to produce a biological response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Question: What characterizes most drugs in terms of molecular weight and origin?

A

Answer: Most drugs are ‘small molecules’ with molecular weights less than 600 and are not endogenous.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Question: Provide examples of emerging therapeutic agents categorized as ‘biologics.’

A

Answer: More ‘biologics’ entering the clinic include antibodies and proteins as therapeutic agents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Question: What is emphasized regarding drug safety, and what factor determines it?

A

Answer: No drug is entirely safe; the balance between efficacy and toxicity is crucial. Drug safety depends on its therapeutic index, which varies for all drugs, making the administration of the right dose essential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Explain this graph

A
  • This graph shows what happens to plasma concentration (mg/ml) over time (s) when a patient takes one tablet.
    -The peak of the graph is when the drug is absorbed into the patient
  • The decrease shows the drug being removed from the system and gets metabolised until no drug is left.
  • 2 dashed lines shown:
    Bottom line is the minimum effective concentration
    Top line is toxic concentration
  • Between the MEC and TC is the therapeutic window and this is the range of effective doses that can be given to a patient.
  • The wider the therapeutic window the wider the range of doses that can be given to a patient.
  • The narrower the therapeutic window, the narrower the range of dosages, thus more caution taken when giving doses of drug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Question: What is the primary goal of administering drugs in the context of a biological response?

A

Answer: Drugs are administered to achieve a biological response that alleviates the symptoms or cause of an illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Question: What is responsible for producing symptoms or causing illnesses at a biological level?

A

Answer: A biological process is responsible for producing the symptoms or causing the illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Question: Describe the nature of a drug target at the molecular level.

A

Answer: At the molecular level, a drug target is usually a biomacromolecule such as a receptor, enzyme, or ion channel involved in the biological process.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Question: What happens when a drug molecule interacts with its molecular target?

A

Answer: The drug molecule interacts with the molecular target and produces a response that is clinically beneficial.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Question: Where is the drug target typically located, emphasizing its context in drug development?

A

Answer: The drug target is not in a test tube; it is buried somewhere in a physiological system, specifically within a patient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Question: How do drugs get to their target?

A

Answer: - In terms of taking the drug orally, the drug enters the mouth then down into the stomach.
- Drug must find a way to not get broken down by the highly acidic stomach acid.
- Assuming it survived, the drug moves int small intestine.
- Small intestine has large surface area, provides maximum absorption.
- Drug is absorbed across the lipid membrane of GI tract and enters bloodstream.
- Drug must avoid absorption of reflux pump.
- If survived, the drug moves through the lipid membrane into the systematic circulation.
- Drug enters the portal vein which leads into the liver.
- Drug must avoid metabolism of the liver.
- If avoided, the drug circulates in the blood to find its target.
- In order for the drug to reach its site of action, it may need to diffuse across another lipophilic membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Question: Name an example of a drug target enzyme involved in the inflammatory response.

A

Answer: Cyclo-oxygenase (COX) is an example of a drug target enzyme involved in the inflammatory response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Question: What role does COX play in the synthesis of prostaglandins (PGs) during inflammation?

A

Answer: COX initiates the PG synthesis cascade by catalyzing the cyclization and oxidation of its substrate arachidonic acid (AA) at the site of inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Question: How do non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and flurbiprofen affect COX?

A

Answer: NSAIDs are competitive inhibitors of COX, binding to the catalytic site. This prevents arachidonic acid (AA) from binding and being converted to PGs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Question: What is the clinical consequence of inhibiting COX with NSAIDs?

A

Answer: Inhibiting COX with NSAIDs leads to a reduction in PG levels, resulting in a decrease in inflammation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Question: Describe a potential side effect associated with the non-specific inhibition of COX in the stomach.

A

Answer: Non-specific inhibition of COX in the stomach reduces prostaglandin levels, making the stomach susceptible to ulceration, as high prostaglandin levels typically protect the stomach wall from degradation by acid.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Question: Identify an example of a drug target receptor involved in bronchial smooth muscle activation

A

Answer: β2 adrenoceptors are an example of drug target receptors involved in bronchial smooth muscle activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Question: What initiates the activation of β2 adrenoceptors in bronchial smooth muscle?

A

Answer: Activation of β2 adrenoceptors in bronchial smooth muscle is initiated by adrenaline and noradrenaline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Question: How do drugs like salbutamol affect β2 adrenoceptors?

A

Answer: Drugs like salbutamol, as β2 adrenoceptor agonists, mimic the effect of the natural ligand and induce the same response.

20
Q

Question: Describe the clinical consequence of activating β2 adrenoceptors with drugs like salbutamol.

A

Answer: The bronchial smooth muscle relaxes, allowing asthmatic patients to breathe more easily.

21
Q

Question: What is the clinical context regarding maintaining the effectiveness of drugs like salbutamol?

A

Answer: To keep stimulating the β2 adrenoceptor and relax the airway, the clinically effective concentration of salbutamol must be maintained. Repeated dosing may not be required if the cause of the asthma attack is no longer present.

22
Q

Question: List the key intermolecular interactions that promote association between a drug and the amino acids in a target protein’s binding site.

A

Answer: Hydrogen bonding, Van der Waals forces (VDW or LDF), ionic/electrostatic interactions, π-π bonding, and dipole interactions are key intermolecular interactions.

23
Q

Question: What determines the types of interactions available for drug molecules?

A

Answer: The functional groups present in a drug molecule determine the types of interactions available.

24
Q

Question: How are physicochemical properties such as water solubility and membrane permeability influenced in drug molecules?

A

Answer: Physicochemical properties, including water solubility and membrane permeability, are dictated by the functional groups present in drug molecules.

25
Q

Question: What role does the tertiary structure of COX play in its function?

A

Answer: The tertiary structure of COX enables the enzyme to perform its function, maintaining the integrity of the active site where catalysis is performed.

26
Q

Question: In the case of COX as a drug target, what is the specific function related to its catalytic activity?

A

Answer: The catalytic activity of COX involves the oxidation and cyclization of arachidonic acid toward prostaglandin (PG) synthesis.

27
Q

Question: Regarding arachidonic acid being bound to COX, what effect do the amino acids bordering the active site of COX have on the substrate, arachidonic acid?

A

Answer: The amino acids that border the active site produce a particular 3D-shape, maximizing interactions between the enzyme and the substrate (arachidonic acid).

28
Q

Question: Why are these interactions between the enzyme and arachidonic acid crucial?

A

Answer: These interactions are crucial to ensure that the substrate (arachidonic acid) is held in the correct position within the active site, facilitating the catalysis of the reaction.

29
Q

Question: How is the tertiary structure of enzymes, such as COX, described?

A

Answer: Enzymes like COX have globular tertiary structures with a surface that excludes small molecules from penetrating their interior.

30
Q

Question: What is a characteristic feature of the active site in enzymes like COX?

A

Answer: The active site is flexible and can expand and contract, akin to a camera shutter, allowing substrates to enter and products to exit.

31
Q

Question: How does the movement of the active site contribute to the catalytic nature of enzymes like COX?

A

Answer: The movement of the active site lowers the activation energy of the reaction by forcing the substrate into a transition-state conformation, making the reaction catalytic.

32
Q

Question: What types of interactions occur between the amino acids bordering the active site and the substrate (arachidonic acid) when it is bound to the COX enzyme?

A

Answer: The interactions are a mixture of hydrogen bonds (H-bonds) and short-range van der Waals interactions. H-bonds are directional and specific for H-bonding groups on the substrate.

33
Q

Question: Why are hydrogen bonds considered specific in the context of substrate interactions with the COX enzyme?

A

Answer: Hydrogen bonds are considered specific because they are directional and form between specific hydrogen-bonding groups on the substrate and the amino acids bordering the active site.

34
Q

Question: What characterizes the short-range van der Waals interactions during the binding of arachidonic acid to the COX enzyme?

A

Answer: Short-range van der Waals interactions occur between the surface of the substrate (arachidonic acid) and the surface of the active site, contributing to the binding.

35
Q

Question: What role does flurbiprofen play in relation to the COX enzyme?

A

Answer: Flurbiprofen functions as a competitive inhibitor of the COX enzyme.

36
Q

Question: How does flurbiprofen block prostaglandin synthesis and reduce the inflammatory response?

A

Answer: Flurbiprofen binds in preference to arachidonic acid, blocking prostaglandin synthesis, which subsequently reduces the inflammatory response.

37
Q

Question: What structural resemblance is necessary for flurbiprofen to compete effectively with the substrate in the COX enzyme’s active site?

A

Answer: To compete with the substrate, flurbiprofen must have some structural resemblance, allowing it to match the 3D shape of the active site.

38
Q

Question: Why must flurbiprofen form stronger interactions with the active site to compete effectively with the substrate?

A

Answer: To compete effectively, flurbiprofen must form stronger interactions with the active site, binding in preference to the substrate.

39
Q

Question: How is the binding process described in the context of flurbiprofen as a competitive inhibitor?

A

Answer: The binding process is dynamic, involving regular association and dissociation of molecules. Effective inhibitors like flurbiprofen need to stay bound longer than the substrate to be effective.

40
Q

Question: How does the NSAID flurbiprofen interact with the COX active site in comparison to arachidonic acid?

A

Answer: Flurbiprofen binds in the COX active site with greater affinity than arachidonic acid.

41
Q

Question: What types of interactions occur between the amino acids bordering the active site and flurbiprofen during binding to COX?

A

Answer: The interactions are a mixture of hydrogen bonds (H-bonds) and short-range van der Waals interactions, similar to the types of interactions observed with the substrate arachidonic acid.

42
Q

Question: Why is it important for flurbiprofen to have greater affinity than arachidonic acid in the COX active site?

A

Answer: Having greater affinity ensures that flurbiprofen competes effectively with arachidonic acid, blocking prostaglandin synthesis and reducing the inflammatory response.

43
Q

Question: What characterizes the short-range van der Waals interactions between flurbiprofen and the COX active site?

A

Answer: Short-range van der Waals interactions occur between the surface of flurbiprofen and the surface of the active site, contributing to the binding process.

44
Q

Question: What is the physiological effect of the activation of β2 adrenoceptors in bronchial smooth muscle by adrenaline and noradrenaline?

A

Answer: Activation of β2 adrenoceptors in bronchial smooth muscle by adrenaline and noradrenaline dilates the airways, making it a treatment for asthma.

45
Q

Question: How does salbutamol function in relation to β2 adrenoceptors?

A

Answer: Salbutamol is a β2 adrenoceptor agonist, mimicking the effect of the natural ligand and inducing the same response more effectively.